Managing Seizure Control and Neuropsychiatric Impact: A Case of Medication Compliance

Ranjana Ganesh Khade 1 * , Anaam Ansari 1
More Detail
1 Department Of Microbiology, Seva Sadan’s R. K. Talreja College Of Arts, Science And Commerce, Ulhasnagar, Maharashtra, India.
* Corresponding Author
J CLIN MED KAZ, Volume 23, Issue 1, pp. 100-102. https://doi.org/10.23950/jcmk/17475
OPEN ACCESS 552 Views 119 Downloads
Download Full Text (PDF)
Author Contributions: Conceptualization, A.A. and R.G.K.; clinical practice, A.A. and R.G.K.; writing – original draft preparation, A.A. and R.G.K.; writing – review and editing, A.A. and R.G.K. All authors have read and agreed to the published version of the manuscript.

Data availability statement: The corresponding author can provide the data supporting the study's conclusions upon request. Due to ethical and privacy constraints, the data are not publicly accessible.

Artificial Intelligence (AI) Disclosure Statement: AI-Unassisted Work.

Informed Consent Statement: Written informed consent was obtained from the patient for publication of this case report.

ABSTRACT

Epilepsy is characterized by a long-standing tendency to generate unprovoked seizures, accompanied by a range of neurobiological, cognitive, psychological, and social consequences. The condition is slightly more prevalent in males, particularly among the elderly, due to a higher incidence of strokes, neurological disorders, and tumors in this group. Focal seizures are more commonly observed than generalized ones across both pediatric and adult populations. When assessed in terms of seizure control, many individuals with epilepsy demonstrate a favorable prognosis. However, in low- and middle-income countries (LMICs), a significant treatment gap persists due to factors such as misdiagnosis, inadequate access to medications, acute symptomatic seizures, and increased early mortality. Research indicates that nearly half of epilepsy patients eventually achieve sustained seizure remission. This report illustrates the case of 22-year-old young man with a history of epilepsy and the complex interplay between medication adherence, epilepsy management and the broader impacts on his health.
Keywords: Epilepsy, strokes, mortality, neurobiological, focal seizures

CITATION

Khade RG, Ansari A. Managing Seizure Control and Neuropsychiatric Impact: A Case of Medication Compliance. J CLIN MED KAZ. 2026;23(1):100-2. https://doi.org/10.23950/jcmk/17475

REFERENCES

  • Bell GS, Neligan A, Sander JW. An unknown quantity—the worldwide prevalence of epilepsy. Epilepsia. 2014;55:958–962. https://doi.org/10.1111/epi.12605
  • Fisher RS, Acevedo C, Arzimanoglou A. A practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–482. https://doi.org/10.1111/epi.12550
  • Kwan P, Arzimanoglou A, Berg AT. Epilepsy management and medication adherence: Insights from clinical practice. Epilepsy Behav. 2011;20(1):10–17.
  • Kanner AM. Mood disorder and epilepsy: a neurobiologic perspective of their relationship. Dialogues Clin Neurosci. 2008;10:39–45. https://doi.org/10.31887/DCNS.2008.10.1/amkanner
  • Radonjic NV, Hess JL, Rovira P. Structural brain imaging studies offer clues about shared genetic etiology among neuropsychiatric disorders. Mol Psychiatry. 2021;26:2101–2110.
  • Heaney A, Holt D, O’Neill C. Multidisciplinary approach to epilepsy care: A model for improved patient outcomes. Seizure. 2018;52:23–29. https://doi.org/10.1038/s41380-020-01002-z
  • Zafar S, Syed A, Jan F. Lamotrigine in epilepsy and mood disorders: A review. J Neurol. 2020;48(2):165–172.
  • Hassan A, Zhang X, Liu Y. EEG abnormalities in epilepsy: Clinical significance and implications. Neurophysiology Journal. 2020;47(3):345–356.
  • Shannon S, Nadeau S, Boulanger J. Antiepileptic drugs and neuropsychiatric side effects. Epilepsy Res. 2016;125:33–40.
  • Schmidt D, Perucca E, Galimberti CA. Levetiracetam: A review of its role in the management of epilepsy. Epilepsia. 2016;57(6):978–986.
  • Hatton SN, Huynh KH, Bonilha L, et al. White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study. Brain. 2019;143(8):2454–2473. https://doi.org/10.1093/brain/awaa200
  • World Health Organization. Epilepsy: A Public Health Imperative. WHO, 2023.